Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Extracellular RNA Sensing by Pattern Recognition Receptors.

Tatematsu M, Funami K, Seya T, Matsumoto M.

J Innate Immun. 2018;10(5-6):398-406. doi: 10.1159/000494034. Epub 2018 Nov 7. Review.

2.

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide.

Takeda Y, Azuma M, Funami K, Shime H, Matsumoto M, Seya T.

Front Immunol. 2018 Mar 14;9:496. doi: 10.3389/fimmu.2018.00496. eCollection 2018.

3.

The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc Min/+ mice.

Ono J, Shime H, Takaki H, Takashima K, Funami K, Yoshida S, Takeda Y, Matsumoto M, Kasahara M, Seya T.

J Biomed Sci. 2017 Oct 17;24(1):79. doi: 10.1186/s12929-017-0387-z.

4.

Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling.

Funami K, Matsumoto M, Oshiumi H, Inagaki F, Seya T.

Biochem Soc Trans. 2017 Aug 15;45(4):929-935. doi: 10.1042/BST20160259. Epub 2017 Jun 19. Review.

PMID:
28630139
5.

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages.

Yoshida S, Shime H, Funami K, Takaki H, Matsumoto M, Kasahara M, Seya T.

PLoS One. 2017 Jan 23;12(1):e0169360. doi: 10.1371/journal.pone.0169360. eCollection 2017.

6.

Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.

Leong CR, Funami K, Oshiumi H, Mengao D, Takaki H, Matsumoto M, Aly HH, Watashi K, Chayama K, Seya T.

Oncotarget. 2016 Oct 18;7(42):68179-68193. doi: 10.18632/oncotarget.11907.

7.

The dataset of proteins specifically interacted with activated TICAM-1.

Funami K, Matsumoto M, Oshiumi H, Obuse C, Seya T.

Data Brief. 2016 Jun 28;8:697-9. doi: 10.1016/j.dib.2016.06.030. eCollection 2016 Sep.

8.

Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells.

Kasamatsu J, Deng M, Azuma M, Funami K, Shime H, Oshiumi H, Matsumoto M, Kasahara M, Seya T.

BMC Immunol. 2016 May 3;17(1):9. doi: 10.1186/s12865-016-0147-y.

9.

14-3-3-zeta participates in TLR3-mediated TICAM-1 signal-platform formation.

Funami K, Matsumoto M, Obuse C, Seya T.

Mol Immunol. 2016 May;73:60-8. doi: 10.1016/j.molimm.2016.03.010. Epub 2016 Apr 6.

PMID:
27058640
10.

Raftlin Controls Lipopolysaccharide-Induced TLR4 Internalization and TICAM-1 Signaling in a Cell Type-Specific Manner.

Tatematsu M, Yoshida R, Morioka Y, Ishii N, Funami K, Watanabe A, Saeki K, Seya T, Matsumoto M.

J Immunol. 2016 May 1;196(9):3865-76. doi: 10.4049/jimmunol.1501734. Epub 2016 Mar 28.

11.

[Nucleic acid pattern recognition for innate sensing of hepatitis B virus (HBV)].

Seya T, Funami K, Matsumoto M, Oshiumi H.

Nihon Rinsho. 2015 Dec;73 Suppl 9:392-6. Japanese. No abstract available.

PMID:
26845965
12.

Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV).

Nakai M, Oshiumi H, Funami K, Okamoto M, Matsumoto M, Seya T, Sakamoto N.

Sensors (Basel). 2015 Oct 23;15(10):27160-73. doi: 10.3390/s151027160. Review.

13.

LRRC59 Regulates Trafficking of Nucleic Acid-Sensing TLRs from the Endoplasmic Reticulum via Association with UNC93B1.

Tatematsu M, Funami K, Ishii N, Seya T, Obuse C, Matsumoto M.

J Immunol. 2015 Nov 15;195(10):4933-42. doi: 10.4049/jimmunol.1501305. Epub 2015 Oct 14.

14.

Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.

Funami K, Matsumoto M, Enokizono Y, Ishii N, Tatematsu M, Oshiumi H, Inagaki F, Seya T.

J Immunol. 2015 Nov 1;195(9):4456-65. doi: 10.4049/jimmunol.1402628. Epub 2015 Sep 25.

15.

Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells.

Ishii N, Funami K, Tatematsu M, Seya T, Matsumoto M.

J Immunol. 2014 Nov 15;193(10):5118-28. doi: 10.4049/jimmunol.1401375. Epub 2014 Oct 8.

16.

Assessment of the Toll-like receptor 3 pathway in endosomal signaling.

Matsumoto M, Funami K, Tatematsu M, Azuma M, Seya T.

Methods Enzymol. 2014;535:149-65. doi: 10.1016/B978-0-12-397925-4.00010-9.

PMID:
24377923
17.

Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling.

Enokizono Y, Kumeta H, Funami K, Horiuchi M, Sarmiento J, Yamashita K, Standley DM, Matsumoto M, Seya T, Inagaki F.

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19908-13. doi: 10.1073/pnas.1222811110. Epub 2013 Nov 19.

18.

Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, Seya T, Takaku H, Shimotohno K.

J Virol. 2013 Jul;87(14):8169-78. doi: 10.1128/JVI.00974-13. Epub 2013 May 15.

19.

Toll-IL-1-receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity.

Matsumoto M, Funami K, Oshiumi H, Seya T.

Prog Mol Biol Transl Sci. 2013;117:487-510. doi: 10.1016/B978-0-12-386931-9.00018-0. Review.

PMID:
23663980
20.

Multi-step regulation of interferon induction by hepatitis C virus.

Oshiumi H, Funami K, Aly HH, Matsumoto M, Seya T.

Arch Immunol Ther Exp (Warsz). 2013 Apr;61(2):127-38. doi: 10.1007/s00005-012-0214-x. Epub 2013 Jan 5. Review.

PMID:
23292079
21.

Cleaved/associated TLR3 represents the primary form of the signaling receptor.

Toscano F, Estornes Y, Virard F, Garcia-Cattaneo A, Pierrot A, Vanbervliet B, Bonnin M, Ciancanelli MJ, Zhang SY, Funami K, Seya T, Matsumoto M, Pin JJ, Casanova JL, Renno T, Lebecque S.

J Immunol. 2013 Jan 15;190(2):764-73. doi: 10.4049/jimmunol.1202173. Epub 2012 Dec 19.

22.

Lipoprotein component associated with hepatitis C virus is essential for virus infectivity.

Shimizu Y, Hishiki T, Ujino S, Sugiyama K, Funami K, Shimotohno K.

Curr Opin Virol. 2011 Jul;1(1):19-26. doi: 10.1016/j.coviro.2011.05.017. Epub 2011 Jun 12. Review.

PMID:
22440563
23.

UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling.

Itoh H, Tatematsu M, Watanabe A, Iwano K, Funami K, Seya T, Matsumoto M.

PLoS One. 2011;6(12):e28500. doi: 10.1371/journal.pone.0028500. Epub 2011 Dec 2.

24.

Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.

Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, Ohsaki Y, Fujimoto T, Takaku H, Wakita T, Baumert TF, Miyanari Y, Shimotohno K.

J Virol. 2010 Nov;84(22):12048-57. doi: 10.1128/JVI.01063-10. Epub 2010 Sep 8.

25.

Lipoprotein lipase and hepatic triglyceride lipase reduce the infectivity of hepatitis C virus (HCV) through their catalytic activities on HCV-associated lipoproteins.

Shimizu Y, Hishiki T, Sugiyama K, Ogawa K, Funami K, Kato A, Ohsaki Y, Fujimoto T, Takaku H, Shimotohno K.

Virology. 2010 Nov 10;407(1):152-9. doi: 10.1016/j.virol.2010.08.011. Epub 2010 Sep 6.

26.

Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense.

Arimoto K, Funami K, Saeki Y, Tanaka K, Okawa K, Takeuchi O, Akira S, Murakami Y, Shimotohno K.

Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15856-61. doi: 10.1073/pnas.1004621107. Epub 2010 Aug 19.

27.

Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.

Sasai M, Tatematsu M, Oshiumi H, Funami K, Matsumoto M, Hatakeyama S, Seya T.

Mol Immunol. 2010 Mar;47(6):1283-91. doi: 10.1016/j.molimm.2009.12.002. Epub 2010 Jan 4.

PMID:
20047764
28.

Hepatitis C virus utilizes lipid droplet for production of infectious virus.

Ogawa K, Hishiki T, Shimizu Y, Funami K, Sugiyama K, Miyanari Y, Shimotohno K.

Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(7):217-28. Review.

29.

Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro.

Sugiyama K, Suzuki K, Nakazawa T, Funami K, Hishiki T, Ogawa K, Saito S, Shimotohno KW, Suzuki T, Shimizu Y, Tobita R, Hijikata M, Takaku H, Shimotohno K.

J Virol. 2009 Jul;83(13):6922-8. doi: 10.1128/JVI.02674-08. Epub 2009 Apr 15.

30.

The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-beta production.

Itoh K, Watanabe A, Funami K, Seya T, Matsumoto M.

J Immunol. 2008 Oct 15;181(8):5522-9.

31.

Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.

Shingai M, Azuma M, Ebihara T, Sasai M, Funami K, Ayata M, Ogura H, Tsutsumi H, Matsumoto M, Seya T.

Int Immunol. 2008 Sep;20(9):1169-80. doi: 10.1093/intimm/dxn074. Epub 2008 Jul 8.

32.

Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers.

Nakamura M, Funami K, Komori A, Yokoyama T, Aiba Y, Araki A, Takii Y, Ito M, Matsuyama M, Koyabu M, Migita K, Taniguchi K, Fujioka H, Yatsuhashi H, Matsumoto M, Ishibashi H, Seya T.

Hepatol Int. 2008 Jun;2(2):222-30. doi: 10.1007/s12072-008-9055-4. Epub 2008 Mar 26.

33.

Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.

Funami K, Sasai M, Oshiumi H, Seya T, Matsumoto M.

J Biol Chem. 2008 Jun 27;283(26):18283-91. doi: 10.1074/jbc.M801013200. Epub 2008 May 1.

34.

Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA.

Funami K, Sasai M, Ohba Y, Oshiumi H, Seya T, Matsumoto M.

J Immunol. 2007 Nov 15;179(10):6867-72.

35.

Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily.

Higuchi M, Matsuo A, Shingai M, Shida K, Ishii A, Funami K, Suzuki Y, Oshiumi H, Matsumoto M, Seya T.

Dev Comp Immunol. 2008;32(2):147-55. Epub 2007 Jun 15.

36.

C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.

Takada E, Okahira S, Sasai M, Funami K, Seya T, Matsumoto M.

Mol Immunol. 2007 Jul;44(15):3633-40. Epub 2007 May 22.

PMID:
17521732
37.

NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.

Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T.

J Immunol. 2006 Dec 15;177(12):8676-83.

38.

Antibodies against human Toll-like receptors (TLRs): TLR distribution and localization in human dendritic cells.

Seya T, Funami K, Taniguchi M, Matsumoto M.

J Endotoxin Res. 2005;11(6):369-74.

PMID:
16303093
39.

[Immunologic tests: CR3 (Mac-1, CD11b/CD18), CR4 (CD11c/CD18)].

Funami K, Seya T.

Nihon Rinsho. 2005 Jul;63 Suppl 7:71-3. Review. Japanese. No abstract available.

PMID:
16111191
40.

Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation.

Uehori J, Fukase K, Akazawa T, Uematsu S, Akira S, Funami K, Shingai M, Matsumoto M, Azuma I, Toyoshima K, Kusumoto S, Seya T.

J Immunol. 2005 Jun 1;174(11):7096-103.

41.

Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.

Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi M, Fukumori Y, Seya T, Matsumoto M.

J Immunol. 2005 Feb 1;174(3):1566-73.

42.

The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.

Funami K, Matsumoto M, Oshiumi H, Akazawa T, Yamamoto A, Seya T.

Int Immunol. 2004 Aug;16(8):1143-54. Epub 2004 Jun 28.

PMID:
15226270
43.

Toll-like receptor 3: a link between toll-like receptor, interferon and viruses.

Matsumoto M, Funami K, Oshiumi H, Seya T.

Microbiol Immunol. 2004;48(3):147-54. Review.

44.

Subcellular localization of Toll-like receptor 3 in human dendritic cells.

Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T.

J Immunol. 2003 Sep 15;171(6):3154-62. Erratum in: J Immunol. 2003 Nov 1;171(9):4934.

45.

Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.

Hazeki K, Masuda N, Funami K, Sukenobu N, Matsumoto M, Akira S, Takeda K, Seya T, Hazeki O.

Eur J Immunol. 2003 Mar;33(3):740-7.

46.

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.

Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T.

Nat Immunol. 2003 Feb;4(2):161-7. Epub 2003 Jan 21.

PMID:
12539043
47.

Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.

Fukui A, Yuasa-Nakagawa T, Murakami Y, Funami K, Kishi N, Matsuda T, Fujita T, Seya T, Nagasawa S.

J Biochem. 2002 Nov;132(5):719-28.

Supplemental Content

Loading ...
Support Center